METHOD OF MINIMALLY INVASIVE TREATMENT OF STRESS URINARY INCONTINENCE IN WOMEN Russian patent published in 2021 - IPC A61K31/728 A61K35/16 A61P21/00 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, in particular to gynecology, and can be used in the treatment of stress urinary incontinence in women who have not completed reproductive function. Method of minimally invasive treatment of stress urinary incontinence in women is characterized by the introduction of autologous plasma enriched with platelets, in combination with 2% unstabilized hyaluronic acid into the submucosal layer of the middle third of the urethra in four points corresponding to 3, 6, 9 and 12 o’clock positions, 1 ml in each point, the needle thickness being 20G and its length - 70 mm, through a Luer applicator, tailored to the individual length of the urethra, measured with a Folley catheter No 14 after emptying the bladder and local anesthesia by cathejell with lidocaine /instilagel.

EFFECT: invention provides increased effectiveness and reduced duration of treatment of women with stress urinary incontinence by stimulating the processes of neocollagenesis and improving the revascularization of tissues, which will contribute to the normalization of the urethrovesical sphincter, reducing the frequency of urination and improving the life quality.

1 cl, 3 ex